verapamil has been researched along with Central Nervous System Diseases in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Syvänen, S | 1 |
| Eriksson, J | 1 |
| Reines, E | 1 |
| Johnsen, A | 1 |
| Husum, D | 1 |
| Jensen, G | 1 |
| Bleifeld, W | 1 |
| Merx, W | 1 |
| Effert, S | 1 |
2 reviews available for verapamil and Central Nervous System Diseases
| Article | Year |
|---|---|
Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; | 2013 |
[Verapamil poisoning. A case with fatal course and literature review].
Topics: Central Nervous System Diseases; Heart Block; Humans; Hypotension; Male; Metabolic Diseases; Middle | 1987 |
1 other study available for verapamil and Central Nervous System Diseases
| Article | Year |
|---|---|
[Clinical pharmacology and adverse effects of various anti-arrhythmic drugs].
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Bone Marrow Diseases; Central Nervous Sys | 1971 |